# Application of a New Type of Whole Blood Coagulation Time Measurement in Evaluating the Hypercoagulable State of Malignant Tumors

> **NCT05939960** · — · UNKNOWN · sponsor: **Tianjin Medical University General Hospital** · enrollment: 354 (estimated)

## Conditions studied

- Neoplasm Metastasis
- Blood Coagulation Disorder With Shortened Coagulation Time (Disorder)
- Venous Thromboembolism

## Interventions

- **DIAGNOSTIC_TEST:** CGT test

## Key facts

- **NCT ID:** NCT05939960
- **Lead sponsor:** Tianjin Medical University General Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** UNKNOWN
- **Start date:** 2023-07-01
- **Primary completion:** 2024-02-28
- **Final completion:** 2024-09-30
- **Target enrollment:** 354 (ESTIMATED)
- **Last updated:** 2023-07-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05939960

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05939960, "Application of a New Type of Whole Blood Coagulation Time Measurement in Evaluating the Hypercoagulable State of Malignant Tumors". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT05939960. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*